64P - The role of endobronchial ultrasound in the management of patients previously treated for lung cancer

Date 28 March 2014
Event ELCC 2014
Session Lunch and poster display session
Topics Imaging, Diagnosis and Staging
Lung and other Thoracic Tumours
Presenter Matthew Evison
Citation Journal of Thoracic Oncology (2014) 9 (Supplement 9): S7-S52. 10.1097/JTO.0000000000000131
Authors M. Evison1, P. Crosbie2, R. Califano3, Y. Summers3, J. Martin2, P. Barber2, R. Booton4
  • 1Institute Of Inflammation And Repair, University of Manchester, M13 9PL - Manchester/UK
  • 2North West Lung Centre, University Hospital South Manchester, M23 9LT - Manchester/UK
  • 3Department Of Medical Oncology, University Hospital South Manchester, M23 9LT - Manchester/UK
  • 4University Of Manchester, Institute of Inflammation and Repair, M13 9PL - Manchester/UK


Safe and effective pathological sampling methods are pivotal in the management of lung cancer patients that have previously undergone either curative intent or palliative treatment. Early diagnosis of localised disease recurrence may facilitate further curative treatment and re-biopsy in disease progression after palliative treatment can inform further management. This study assessed the safety and effectiveness of bronchoscopy with radial and linear endobronchial ultrasound (EBUS) in patients with suspected lung cancer recurrence or progression following treatment.